Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika J Olson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
ACS Chemical Biology|October 1, 2014
Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptorIlaria Lamberto, Bernhard C Lechtenberg, Erika J Olson, et al.
Nature Chemistry|February 22, 2017
Chemoproteomic profiling and discovery of protein electrophiles in human cellsMegan L Matthews, Lin He, Benjamin D Horning, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma StabilityErika J Olson, Bernhard C Lechtenberg, Chunxia Zhao, et al.
Chemical Science|September 21, 2022
Direct observation of peptide hydrogel self-assemblyZoë C Adams, Erika J Olson, Tania L Lopez-Silva, et al.
ACS Central Science|September 29, 2021
Activity-Based Hydrazine Probes for Protein Profiling of Electrophilic Functionality in Therapeutic TargetsZongtao Lin, Xie Wang, Katelyn A Bustin, et al.
European Journal of Medicinal Chemistry|November 4, 2024
Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
European Journal of Medicinal Chemistry|March 25, 2024
Lipidation and PEGylation Strategies to Prolong the <i>in Vivo</i> Half-Life of a Nanomolar EphA4 Receptor AntagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
Msystems|March 23, 2022
High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune ResponseTai L Ng, Erika J Olson, Tae Yeon Yoo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
ACS Chemical Biology|October 1, 2014
Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptorIlaria Lamberto, Bernhard C Lechtenberg, Erika J Olson, et al.
Nature Chemistry|February 22, 2017
Chemoproteomic profiling and discovery of protein electrophiles in human cellsMegan L Matthews, Lin He, Benjamin D Horning, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma StabilityErika J Olson, Bernhard C Lechtenberg, Chunxia Zhao, et al.
Chemical Science|September 21, 2022
Direct observation of peptide hydrogel self-assemblyZoë C Adams, Erika J Olson, Tania L Lopez-Silva, et al.
ACS Central Science|September 29, 2021
Activity-Based Hydrazine Probes for Protein Profiling of Electrophilic Functionality in Therapeutic TargetsZongtao Lin, Xie Wang, Katelyn A Bustin, et al.
European Journal of Medicinal Chemistry|November 4, 2024
Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
European Journal of Medicinal Chemistry|March 25, 2024
Lipidation and PEGylation Strategies to Prolong the <i>in Vivo</i> Half-Life of a Nanomolar EphA4 Receptor AntagonistMaricel Gomez-Soler, Erika J Olson, Elena Rubio de la Torre, et al.
Msystems|March 23, 2022
High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune ResponseTai L Ng, Erika J Olson, Tae Yeon Yoo, et al.
Pageof 1